Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth Conference
SEATTLE, Aug. 06, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to […]